Literature DB >> 10594200

Relaparotomy in peritonitis: prognosis and treatment of patients with persisting intraabdominal infection.

T Koperna1, F Schulz.   

Abstract

Some patients are prone to persisting intraabdominal infection regardless of initial eradication of the source of infection. Our aim was to characterize patients who had to undergo relaparotomy for persisting abdominal sepsis using simple clinical parameters and to define those patients who are susceptible to benefit of aggressive surgical treatment by early and repeated reoperations to control multiple organ dysfunction syndrome (MODS) caused by ongoing intraabdominal infection. Persisting abdominal sepsis was the cause of death in all of our patients who had to undergo relaparotomy. Controlling persisting abdominal sepsis should achieve a reduction in the tremendously high mortality rate. Performing a case-control study, we retrospectively reviewed 523 consecutive patients with secondary peritonitis treated from 1986 to 1996 and focused our attention on 105 patients, in whom standard surgical treatment of secondary peritonitis failed and who had to undergo relaparotomy for persisting abdominal sepsis (study group). Overall, there was no significant difference in the postoperative mortality rate between "planned relaparotomy" and "relaparotomy on demand" (54.5% versus 50. 6%). Equally clear risk estimations were given preoperatively by both the Acute Physiology and Chronic Health Evaluation (APACHE) II and the Goris scores. There was a significant difference between patients of the control group and patients of the study group with regard to preoperative APACHE II score, Goris score, age >70 years, albumin <30 g/L, extent of peritonitis, and outcome (p = 0.0001). Reexploration performed more than 48 hr after the initial operation resulted in a significantly higher mortality rate (76.5% versus 28%; p = 0.0001). However, the time of reoperation had no significant impact on survival in patients with an APACHE II score of > or = 26, because physiologic derangement is such that only a few patients could benefit from reoperation. The lowest mortality rate (9%) was achieved in patients who underwent reoperation on demand within 48 hr. We conclude that patients >70 years of age with secondary peritonitis extending over the entire abdomen and a greater degree of physiologic compromise (serum albumin levels <30 g/L, preoperative APACHE II scores >20, and existing organ failure measured by the Goris score) are at high risk for developing persistent intraabdominal infection. Our data show that timely relaparotomy provides the only surgical option that significantly improves outcome. However, aggressive surgical treatment has reached its limit in patients whose source of infection could not be controlled at the initial operation. To improve overall survival the decision to perform a relaparotomy on demand after an initially successful eradication of the source of infection must be made within 48 hr, at least before MODS emerges.

Entities:  

Mesh:

Year:  2000        PMID: 10594200     DOI: 10.1007/s002689910007

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  50 in total

Review 1.  Management of peritonitis in the critically ill patient.

Authors:  Carlos A Ordoñez; Juan Carlos Puyana
Journal:  Surg Clin North Am       Date:  2006-12       Impact factor: 2.741

2.  Staged abdominal repair for treatment of moderate to severe secondary peritonitis.

Authors:  Fatih Agalar; Erol Eroglu; Mahmut Bulbul; Canan Agalar; Omar Ridvan Tarhan; Mustafa Sari
Journal:  World J Surg       Date:  2005-02       Impact factor: 3.352

Review 3.  [Peritonitis: attempt to evaluate therapeutic surgical options].

Authors:  W Teichmann; C Pohland; T Mansfeld; B Herbig
Journal:  Chirurg       Date:  2008-04       Impact factor: 0.955

4.  Complications requiring reoperation after gastrectomy for gastric cancer: 17 years experience in a single institute.

Authors:  Sung Jin Oh; Won Beom Choi; Jyewon Song; Woo Jin Hyung; Seung Ho Choi; Sung Hoon Noh
Journal:  J Gastrointest Surg       Date:  2008-10-11       Impact factor: 3.452

5.  Postoperative Peritonitis After Digestive Tract Surgery: Surgical Management and Risk Factors for Morbidity and Mortality, a Cohort of 191 Patients.

Authors:  Thierry Bensignor; Jérémie H Lefevre; Ben Creavin; Najim Chafai; Thomas Lescot; Thévy Hor; Clotilde Debove; François Paye; Pierre Balladur; Emmanuel Tiret; Yann Parc
Journal:  World J Surg       Date:  2018-11       Impact factor: 3.352

6.  Preoperative risk factors for mortality after relaparotomy: analysis of 254 patients.

Authors:  Isidro Martínez-Casas; Juan J Sancho; Esther Nve; Maria-José Pons; Estela Membrilla; Luis Grande
Journal:  Langenbecks Arch Surg       Date:  2009-07-18       Impact factor: 3.445

7.  The impact of standardized protocol implementation for surgical damage control and temporary abdominal closure after emergent laparotomy.

Authors:  Tyler J Loftus; Philip A Efron; Trina M Bala; Martin D Rosenthal; Chasen A Croft; Michael S Walters; R Stephen Smith; Frederick A Moore; Alicia M Mohr; Scott C Brakenridge
Journal:  J Trauma Acute Care Surg       Date:  2019-04       Impact factor: 3.313

Review 8.  [Updated definition of sepsis : Implications for diagnostics and therapy principles].

Authors:  N Schlegel
Journal:  Chirurg       Date:  2017-01       Impact factor: 0.955

Review 9.  Current concepts in peritonitis.

Authors:  Mark A Malangoni
Journal:  Curr Gastroenterol Rep       Date:  2003-08

10.  Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI)).

Authors:  K Reinhart; F M Brunkhorst; H-G Bone; J Bardutzky; C-E Dempfle; H Forst; P Gastmeier; H Gerlach; M Gründling; S John; W Kern; G Kreymann; W Krüger; P Kujath; G Marggraf; J Martin; K Mayer; A Meier-Hellmann; M Oppert; C Putensen; M Quintel; M Ragaller; R Rossaint; H Seifert; C Spies; F Stüber; N Weiler; A Weimann; K Werdan; T Welte
Journal:  Ger Med Sci       Date:  2010-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.